Sata M - Search Results

1

Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: a multicenter study.

Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. Among authors: sata m. J Med Virol. 2013 Jan;85(1):65-70. doi: 10.1002/jmv.23428. J Med Virol. 2013. PMID: 23154876

2

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.

Nagao Y, Kawaguchi T, Ide T, Sata M. Nagao Y, et al. Among authors: sata m. Virol J. 2012 Nov 22;9:282. doi: 10.1186/1743-422X-9-282. Virol J. 2012. PMID: 23173649 Free PMC article.

3

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin.

Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. Among authors: sata m. BMC Infect Dis. 2012 Nov 27;12:324. doi: 10.1186/1471-2334-12-324. BMC Infect Dis. 2012. PMID: 23181537 Free PMC article. Clinical Trial.

4

Baseline factors and very early viral response (week 1) for predicting sustained virological response in telaprevir-based triple combination therapy for Japanese genotype 1b chronic hepatitis C patients: a multicenter study.

Shimada N, Toyoda H, Tsubota A, Ide T, Takaguchi K, Kato K, Kondoh M, Matsuyama K, Kumada T, Sata M. Shimada N, et al. Among authors: sata m. J Gastroenterol. 2014 Nov;49(11):1485-94. doi: 10.1007/s00535-013-0918-7. Epub 2013 Nov 28. J Gastroenterol. 2014. PMID: 24287582 Clinical Trial.

5

Characteristics and outcomes of HCV genotype-1-infected patients treated with peginterferon and ribavirin combination therapy with discordant HCV responses 4 and 12 weeks after starting therapy.

Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N. Toyoda H, et al. Among authors: sata m. Intervirology. 2014;57(5):289-96. doi: 10.1159/000362721. Epub 2014 Jun 28. Intervirology. 2014. PMID: 24992890

6

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.

Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M. Kuwahara R, et al. Among authors: sata m. J Med Virol. 2004 Jan;72(1):26-34. doi: 10.1002/jmv.10558. J Med Virol. 2004. PMID: 14635007

7

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: sata m. J Gastroenterol. 2005 Feb;40(2):148-56. doi: 10.1007/s00535-004-1519-2. J Gastroenterol. 2005. PMID: 15770398

8

Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.

Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. Ikeda M, et al. Among authors: sata m. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):122-8. doi: 10.1111/j.1440-1746.2005.04083.x. J Gastroenterol Hepatol. 2006. PMID: 16706823

9

A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.

Ogata K, Kashiwagi T, Iwahashi J, Hara K, Honda H, Ide T, Kumashiro R, Kohara M, Sata M, Watanabe H, Hamada N. Ogata K, et al. Among authors: sata m. Arch Virol. 2008;153(8):1575-9. doi: 10.1007/s00705-008-0143-5. Epub 2008 Jul 1. Arch Virol. 2008. PMID: 18592133

10

A randomized study of extended treatment with peginterferon alpha-2b plus ribavirin based on time to HCV RNA negative-status in patients with genotype 1b chronic hepatitis C.

Ide T, Hino T, Ogata K, Miyajima I, Kuwahara R, Kuhara K, Sata M. Ide T, et al. Among authors: sata m. Am J Gastroenterol. 2009 Jan;104(1):70-5. doi: 10.1038/ajg.2008.60. Am J Gastroenterol. 2009. PMID: 19098852 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,459 results

Search Page

Filters